InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Quirk Gerald E. Officer active across 1 company, notably Syros Pharmaceuticals, Inc.. Cumulatively, 4 filings have been published. Split: 0 buy · 1 sell. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Quirk Gerald E is linked to Syros Pharmaceuticals, Inc. as Chief Legal & Compliance Offic. He has 4 filings in total, and across the 4 most recent filings available, the transactions cover the period from 2023-10-20 to 2024-11-20, with EUR 9741 in sales and EUR 0 in purchases. The most frequent transaction nature is Levée d'options.